Top Markets
Coin of the day
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Rang in Aktien #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Aktienkurs
$59.98
Zuletzt synchronisiert: 2024-12-13
Marktkapitalisierung
$1.22B
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Longboard Pharmaceuticals, Inc. (LBPH)

Kategorie

Kursverlauf für Longboard Pharmaceuticals, Inc. (LBPH)
Höchster Schlusskurs: $59.98 am 2024-12-01

Niedrigster Schlusskurs: $16.35 am 2021-03-01
Kursverlauf der Aktie von Longboard Pharmaceuticals, Inc. von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2024 1,066.59%
2023 27.45%
2022 -27.54%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH